Serbia - serbisk - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

bayer d.o.o. beograd - ципротерон -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate; povidone - inoperable prostatic carcinoma. because of its anti-androgenic effect androcur is indicated for the treatment of inoperable prostatic carcinoma in patients who have failed primary hormonal manipulation or who are at risk from cardiovascular disease and/or who are intolerant of oestrogen therapy. indications as at 1 june 1995: inoperable prostatic carcinoma to suppress 'flare' with initial lhrh analogue therapy; in long term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - cyproterone acetate, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; maize starch; colloidal anhydrous silica; povidone - women: moderately severe to severe signs of androgenization. moderately severe/severe forms of hirsutism.moderately severe/severe androgen-dependent loss of scalp hair (moderately severe/severe androgenic alopecia). moderately severe/severe forms of acne and/or seborrhoea associated with other features of androgenization.cyproterone acetate inhibits the influence of male sex hormones which are also produced by the female. it is thus possible to treat diseases in women caused either by increased production of androgens or a particular sensitivity to these hormones. hirsutism and alopecia may be expected to recur over a period of time after cessation of treatment.if androcur is taken during pregnancy, the properties of the preparation may lead to signs of feminisation in the male foetus. therefore, in women of childbearing potential, pregnancy must be excluded at the commencement of treatment and ethinyloestradiol taken as well to ensure contraception. this also promotes regular menstruation.men:reduction of drive in sexual deviations androcur reduces the force of the sexual urge in men with sexual deviations. whilst under treatment the man can control himself better in a predisposing stimulatory situation, but there is no influence on any deviating direction of sexual drive. abnormal patterns of sexual behaviour require treatment when they are distressing to the patient. a pre-requisite for therapy is the desire by the patient for treatment.androcur therapy should be supplemented by psychotherapeutic and sociotherapeutic measures in order to exploit the period of reduced drive for personal and social re-orientation.inoperable prostatic carcinoma to suppress "flare" with initial lhrh analogue therapy in long term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

bayer healthcare sas - cyprotérone (acétate de) 50 mg - comprimé - 50 mg - pour un comprimé > cyprotérone (acétate de 50 mg - antiandrogènes non associés - classe pharmacothérapeutique : antiandrogènes non associés - code atc : g03ha01androcur est un médicament hormonal qui s’oppose aux effets des hormones sexuelles mâles (androgènes), produites également en faible quantité par l’organisme féminin.chez la femme, ce médicament est préconisé dans le traitement de certaines maladies hormonales se manifestant par une augmentation du système pileux. vous ne devez prendre de l’acétate de cyprotérone à 50 mg que lorsque l’utilisation d’acétate de cyprotérone à plus faible dose ou d'autres options de traitement n'a pas permis d’obtenir des résultats satisfaisants.chez l’homme, ce médicament est préconisé pour atténuer les symptômes du cancer de la prostate.

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bayer hispania s.l. - ciproterona acetato - comprimido - 50 mg - ciproterona acetato 50 mg - ciproterona

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bayer ag, nemecko - cyproterón - 34 - antihormona

Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bayer weimar gmbh und co. kg - germania - cyproteronum - compr. - 50mg - antiandrogeni antiandrogeni

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

bayer ag, leverkusen array - 2141 cyproteron-acetÁt - injekční roztok - 300mg - cyproteron

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

bayer portugal, lda. - ciproterona - solução injetável - 300 mg/3 ml - ciproterona, acetato 100 mg/ml - cyproterone - n/a - duração do tratamento: longa duração

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

bayer portugal, lda. - ciproterona - comprimido - 100 mg - ciproterona, acetato 100 mg - cyproterone - n/a - duração do tratamento: longa duração